A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
Condition: 18-42 Year Old Healthy Vaccinia-naïve SubjectsInterventions: Biological: MVA BN®; Biological: ACAM2000®Sponsors: Bavarian Nordic; United States Army Medical Research Institute of Infectious DiseasesRecruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials